内視鏡治療を行う場合の抗血小板・抗凝固薬の取り扱い

書誌事項

タイトル別名
  • HOW ANTIPLATELETS AND ANTICOAGULANTS SHOULD BE MANAGED IN ENDOSCOPIC TREATMENT

この論文をさがす

抄録

In performing endoscopic treatment in patients treated with antiplatelets or anticoagulants, the administration is suspended to prevent intraoperative and postoperative bleeding. However, suspension of the administration naturally increases the risk of thromboembolism, which may lead to serious complications. Therefore, in consideration of these two opposing risks, the Endoscopy Department established provisional rules concerning the administration of anti-platelets and anticoagulants during endoscopic treatment by obtaining cooperation from related departments in the hospital. Although these rules were determined without clear evidence in Japan, they are considered to be meaningful in that they were established through consultation with related departments.

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (31)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ